ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer (PrTK03)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01436968
Recruitment Status : Recruiting
First Posted : September 20, 2011
Last Update Posted : April 12, 2018
Sponsor:
Information provided by (Responsible Party):
Advantagene, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2020
  Study Completion Date : No date given